Dr. Matthew Sherwood, MD

Dr. Sherwood practices at Inova Fairfax Hospital - Unit in Falls Church, Virginia.

Dr. Sherwood's NPI, 1245356435, was assigned on March 21, 2007. Dr. Sherwood graduated from Emory University School of Medicine in 2006. Dr. Sherwood holds Virginia license 0101260144.

Dr. Sherwood's primary practice is Inova Fairfax Hospital - Unit, at 3300 Gallows Rd, Falls Church, VA 22046 in Falls Church City. The practice phone is (703) 698-3659.

Dr. Sherwood's primary practice is Inova Fairfax Hospital - Unit in Falls Church, Virginia. Dr. Sherwood is also affiliated with Inova Fairfax Hospital. The medical group on file is Inova Urgent Care Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sherwood practices, 2 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Sherwood's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Sherwood's licenses on file in 2 states: Virginia and Massachusetts.

CMS data shows 892 Medicare services from Dr. Sherwood across 15 procedure codes in 2024, for 446 Medicare patients. Medicare paid $149,001 for them.

CMS counts 446 Medicare patients who saw Dr. Sherwood in 2024. The largest group is 75 to 84, with 201 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sherwood's median patient age at 73, with 39% women.

In 2024, Dr. Sherwood wrote 809 Medicare Part D claims for 139 patients. 93% of them were for generic drugs. CMS names the drug for 682 of them, across 20 drugs with 11 or more claims each, at $56,261 in total drug cost. In 2023, CMS named 442 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Sherwood for performance year 2024, reported as part of a group. Dr. Sherwood accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sherwood as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 87 papers to Dr. Sherwood, published from 2012 to 2025. 2020 was the busiest year, with 11. The most frequent topics are Percutaneous Coronary Intervention, Myocardial Infarction and Transcatheter Aortic Valve Replacement. Dr. Sherwood has published most often in JACC Cardiovasc Interv. Dr. Sherwood's most frequent co-authors are Wayne B. Batchelor, MD, Behnam Nonahal Tehrani, MD and Abdulla Al Damluji, MD, MPH.

Dmand AI links Dr. Sherwood to 3 clinical trials. 3 are still active or recruiting. Conditions studied include Atrial Fibrillation, Stroke and Ventricular Outflow Obstruction. Boston Scientific Corporation sponsors the most, 2.

CMS Open Payments shows 541 general payments to Dr. Sherwood from 22 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 44% of the total. Medtronic, Inc. paid the most, $151,941. It also lists 10 research payments totaling $6,017 from 2019 to 2025.

Dr. Sherwood graduated from Emory University School of Medicine in 2006.